Výsledky vyhledávání - "Vivianne C.G. Tjan Heijnen"

Akademický článek

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

Autor: Judith L. Gulikers, MSc, G.D. Marijn Veerman, MD, PhD, Merel Jebbink, MD, PhD, Paul D. Kruithof, PharmD, Christi M.J. Steendam, MD, PhD, René J. Boosman, PhD, Ron H.J. Mathijssen, MD, PhD, Vivianne C.G. Tjan-Heijnen, MD, PhD, Johanna H.M. Driessen, PhD, Safiye Dursun, MD, Egbert F. Smit, MD, PhD, Anne-Marie C. Dingemans, MD, PhD, Robin M.J.M. van Geel, PharmD, PhD, Sander Croes, PharmD, PhD, Lizza E.L. Hendriks, MD, PhD

Publikováno v: JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100656- (2024)

Introduction: Brain metastases (BM) are common in patients with advanced EGFR-mutated (EGFRm+) NSCLC. Despite good BM-related outcomes of osimertinib, several patients still experience intracranial progression. A possible explanation is pharmacologic

Externí odkaz: https://doaj.org/article/b8cb56c1a21d4838abe7a2a929f0a009

Zobrazit plný text záznamu

Akademický článek

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trialResearch in context

Autor: Vivianne C.G. Tjan-Heijnen, Senna W.M. Lammers, Sandra M.E. Geurts, Ingeborg J.H. Vriens, Astrid C.P. Swinkels, Carolien H. Smorenburg, Maurice J.C. van der Sangen, Judith R. Kroep, Hiltje de Graaf, Aafke H. Honkoop, Frans L.G. Erdkamp, Wilfred K. de Roos, Sabine C. Linn, Alexander L.T. Imholz

Publikováno v: EClinicalMedicine, Vol 58, Iss , Pp 101901- (2023)

Summary: Background: The DATA study evaluated the use of two different durations of anastrozole in patients with hormone receptor-positive breast cancer who were disease-free after 2–3 years of tamoxifen. We hereby present the follow-up analysis, w

Externí odkaz: https://doaj.org/article/5623c66d14bc4b84bad476914391d5ba

Zobrazit plný text záznamu

Akademický článek

Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography

Autor: Rob M. G. van Bommel, Roy Weber, Adri C. Voogd, Joost Nederend, Marieke W. J. Louwman, Dick Venderink, Luc J. A. Strobbe, Matthieu J. C. Rutten, Menno L. Plaisier, Paul N. Lohle, Marianne J. H. Hooijen, Vivianne C.G. Tjan-Heijnen, Lucien E. M. Duijm

Publikováno v: BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)

Abstract Background To determine the proportion of “true” interval cancers and tumor characteristics of interval breast cancers prior to, during and after the transition from screen-film mammography screening (SFM) to full-field digital mammograp

Externí odkaz: https://doaj.org/article/3997255a6c51455fb91675b8ac065d3d

Zobrazit plný text záznamu

Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study

Autor: Evelien J.M. de Jong, Lydia G. van der Geest, Marc G. Besselink, Stefan A.W. Bouwense, Jeroen Buijsen, C.H.C. Dejong, Bas G. Koerkamp, Lara R. Heij, Ignace H.J.T. de Hingh, Chantal Hoge, Geert Kazemier, Hanneke W.M. van Laarhoven, Vincent E. de Meijer, Martijn W.J. Stommel, Vivianne C.G. Tjan-Heijnen, Liselot B.J. Valkenburg-van Iersel, Johanna W. Wilmink, Sandra M.E. Geurts, Judith de Vos-Geelen

Publikováno v: HPB, 24(9), 1433-1442. John Wiley and Sons Inc.
Hpb, 24, 1433-1442
Hpb, 24(9), 1433-1442. ELSEVIER SCI LTD
HPB, 24(9), 1433-1442. ELSEVIER SCI LTD
HPB, 24(9), 1433-1442. John Wiley & Sons Inc.
Hpb, 24, 9, pp. 1433-1442
Dutch Pancreatic Cancer Group 2022, ' Treatment and overall survival of four types of non-metastatic periampullary cancer : nationwide population-based cohort study ', HPB, vol. 24, no. 9, pp. 1433-1442 . https://doi.org/10.1016/j.hpb.2022.01.009
HPB : official jouarnal of The International Hepato-Pancreato-Biliary 24(9), 1433-1442 (2022). doi:10.1016/j.hpb.2022.01.009

HPB : official jouarnal of The International Hepato-Pancreato-Biliary 24(9), 1433-1442 (2022). doi:10.1016/j.hpb.2022.01.009
Published by Elsevier, [London]

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d6453b8e716feb8032d8d409af21309
https://pure.amc.nl/en/publications/treatment-and-overall-survival-of-four-types-of-nonmetastatic-periampullary-cancer(a581a34c-b4d2-47b7-b5b1-3ad2620f9594).html

Zobrazit plný text záznamu

Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial

Autor: Sonja B. Vliek, Iris Noordhoek, Elma Meershoek-Klein Kranenbarg, Annelot G.J. van Rossum, Vincent O. Dezentje, Agnes Jager, J.W. Esmeralda Hokken, Hein Putter, Annette W.G. van der Velden, Mathijs P. Hendriks, Sandra D. Bakker, Yvonne E.A. van Riet, Vivianne C.G. Tjan-Heijnen, Johanneke E.A. Portielje, Judith R. Kroep, Johan W.R. Nortier, Cornelis J.H. van de Velde, Sabine C. Linn

Publikováno v: Journal of Clinical Oncology, 68:JCO.21.00311. American Society of Clinical Oncology
Journal of Clinical Oncology, 40(25), 2934-2945. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 40(25), 2934-2945. American Society of Clinical Oncology

PURPOSE For postmenopausal patients with breast cancer, previous subgroup analyses have shown a modest benefit from adjuvant bisphosphonate treatment. However, the efficacy of oral nitrogen-containing bisphosphonates such as ibandronate is unclear in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22b0aab2385e3db65347f3b4df1ca8cc
https://pure.eur.nl/en/publications/5987355e-acd2-4c89-a4f5-c8277930d56d

Zobrazit plný text záznamu

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting

Autor: Adri C. Voogd, Maaike de Boer, Shanly C. Seferina, M. Wouter Dercksen, Bram Ramaekers, Vivianne C.G. Tjan Heijnen, Agnes J. van de Wouw, Roel J.W. van Kampen, Franchette W P J van den Berkmortel, Manuela A. Joore

Publikováno v: Oncotarget
Oncotarget, 8(45), 79223-79233. Impact Journals LLC

// Shanly C. Seferina 1,2 , Bram L.T. Ramaekers 8 , Maaike de Boer 1,2 , M. Wouter Dercksen 3 , Franchette van den Berkmortel 4 , Roel J.W. van Kampen 1,5 , Agnes J. van de Wouw 6 , Adri C. Voogd 1,2,7 , Vivianne C.G. Tjan Heijnen 1,2 , Manuela A. Jo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430b4bfabf9195c77c37b341669d15d8
https://doi.org/10.18632/oncotarget.16985

Zobrazit plný text záznamu

Prognostic DNA methylation markers for hormone receptor breast cancer

Autor: Tim C. de Ruijter, Frank C T van der Heide, Kim M. Smits, Vivianne C.G. Tjan Heijnen, Maureen J.B. Aarts, Manon van Engeland

Publikováno v: Breast Cancer Research : BCR
Breast Cancer Research, Vol 22, Iss 1, Pp 1-12 (2020)

Background In patients with hormone receptor-positive breast cancer, differentiating between patients with a low and a high risk of recurrence is an ongoing challenge. In current practice, prognostic clinical parameters are used for risk prediction.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e446cd16d9484ad9aa3f654d5682221d
https://doi.org/10.1186/s13058-020-1250-9

Zobrazit plný text záznamu

Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer 3

Autor: Juliane Farthmann, Viktor Magdolen, Panagiotis Prezas, Manfred Schmitt, Paul N. Span, Maroulio Talieri, Leon Holzscheiter, Vivianne C.G. Tjan-Heijnen, Fred C.G.J. Sweep, Gustavo B. Baretton, Julia c. Biermann, Thomas Luther, Matthias Kotzsch

Publikováno v: Clinical Chemistry. 52:1070-1079

Background: The human tissue kallikrein gene family (KLK1 to KLK15) encodes a group of 15 serine proteases (hK1 to hK15), several of which have been implicated in cancer-related processes.Methods: We established a specific quantitative reverse transc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e28d27af9a5cb45b618a5e9bfcaf29ce
https://doi.org/10.1373/clinchem.2005.065599

Zobrazit plný text záznamu

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

Autor: Ruth Pettengell, Damien C. Weber, David Cameron, Jeffrey Crawford, Michael Ellis, Vivianne C.G. Tjan-Heijnen, Matti Aapro, Julia Bohlius, Jan Walewski, Nora Kearney, Christoph C. Zielinski, Gary H. Lyman

Publikováno v: European Journal of Cancer, 42, 2433-53
European Journal of Cancer, 42, 15, pp. 2433-53

Contains fulltext : 50078tjan-heijnen.pdf (Publisher’s version ) (Closed access) Chemotherapy-induced neutropenia is not only a major risk factor for infection-related morbidity and mortality, but is also a significant dose-limiting toxicity in can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::787c80ffffbc3197c098a9acf93aea7e
http://hdl.handle.net/2066/50078

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání